---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-105457"
form_type: "8-K"
ticker: "ALLR"
cik: "0001860657"
company_name: "Allarity Therapeutics, Inc."
filed_at: "2026-10-01T12:00:17+00:00"
generated_at: "2026-10-12T14:15:58.820149+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "medium"
source: SEC EDGAR
---

# Allarity cites patent awards, CLIA lab certification to advance stenoparib DRP companion diagnostic

## Summary
- Allarity says recent patent awards plus CLIA certification of its in-house lab let it retain sole control of the stenoparib-DRP test as a companion diagnostic.
- Stenoparib-DRP comprises a 414-gene expression signature including genes tied to WNT pathway activity; DRP tests have been developed for dozens of cancer therapies.
- At AACR 2026, an exploratory analysis of a prior Phase 2 cohort of advanced ovarian cancer patients on twice-daily stenoparib linked higher pretreatment DRP scores to longer overall survival.
- CEO Thomas Jensen said the DRP-survival association helps inform the path toward FDA approval; stenoparib remains the principal development focus.
- No financial results, patient counts, partnership terms or pivotal-trial timeline were disclosed in the update.

## SEC filing metadata
- accession: 0001213900-26-105457
- form_type: 8-K
- ticker: ALLR
- cik: 0001860657
- company_name: Allarity Therapeutics, Inc.
- filed_at: 2026-10-01T12:00:17+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: medium
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860657/000121390026105457/0001213900-26-105457-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860657/000121390026105457/ea0307298-8k_allarity.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-105457
- JSON: https://secwatch.observer/filing/0001213900-26-105457.json
- Plain text: https://secwatch.observer/filing/0001213900-26-105457.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.